The SynapTx™ ecosystem
Integrating molecular, formulation, pharmacokinetic, and regulatory intelligence before development begins.
Input 01
Molecular Properties
- Solubility
- Stability
- Permeability
Input 02
Preclinical Data
- In vitro studies
- In vivo studies
- Toxicology
Input 03
Formulation Variables
- Excipients
- Release systems
- Delivery architecture
Input 04
Clinical Evidence
- Literature
- Comparator products
- Clinical outcomes
Input 05
CMC Parameters
- Manufacturability
- Scale-up feasibility
- Process robustness
Input 06
Regulatory Intelligence
- ICH expectations
- Product precedents
- Development pathways
Input 01
Molecular Properties
- Solubility
- Stability
- Permeability
Input 02
Preclinical Data
- In vitro studies
- In vivo studies
- Toxicology
Input 03
Formulation Variables
- Excipients
- Release systems
- Delivery architecture
Input 04
Clinical Evidence
- Literature
- Comparator products
- Clinical outcomes
Input 05
CMC Parameters
- Manufacturability
- Scale-up feasibility
- Process robustness
Input 06
Regulatory Intelligence
- ICH expectations
- Product precedents
- Development pathways
Inputs
→
SynapTx™
Predictive Development Engine
PK Simulation
Exposure Modelling
Stability Prediction
Risk Assessment
Formulation Optimisation
Translational Assessment
Integrating scientific, formulation, pharmacokinetic, and regulatory inputs to identify the pathway of highest probability.
→
Outputs
Output 01
Human PK Prediction
- Exposure profiles
- Dose–response
- Variability assessment
Output 02
Formulation Strategy
- System selection
- Risk landscape
- Excipient rationale
Output 03
Clinical Development Pathway
- Phase strategy
- Dose rationale
- Study design
Output 04
CMC Alignment
- Manufacturability
- Scale readiness
- Process validation
Output 05
Risk Mitigation Plan
- Failure mode analysis
- De-risking strategy
- Contingency design
Output 06
Technology Transfer Readiness
- Process package
- Scale documentation
- GMP alignment
Output 01
Human PK Prediction
- Exposure profiles
- Dose–response
- Variability assessment
Output 02
Formulation Strategy
- System selection
- Risk landscape
- Excipient rationale
Output 03
Clinical Development Pathway
- Phase strategy
- Dose rationale
- Study design
Output 04
CMC Alignment
- Manufacturability
- Scale readiness
- Process validation
Output 05
Risk Mitigation Plan
- Failure mode analysis
- De-risking strategy
- Contingency design
Output 06
Technology Transfer Readiness
- Process package
- Scale documentation
- GMP alignment
From data to development decisions
SynapTx™ continuously integrates scientific, formulation, pharmacokinetic, and regulatory inputs to identify development pathways with the highest probability of clinical and manufacturing success.